Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 230 to 279 of 3730 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Filtered\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
115\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein-like 1; zinc-finger protein in men1 region. [source:refseq;acc:nm\_006782]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
385\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
543\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.41039\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
116\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-parvin (calponin-like integrin-linked kinase binding protein) (ch-ilkbp). [source:swissprot;acc:q9nvd7]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
668\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
475\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.40632\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 1 (ec 2.7.1.33) (pantothenic acid kinase 1) (hpank1) (hpank). [source:swissprot;acc:q8te04]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
21185\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
117\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 2, mitochondrial precursor (ec 2.7.1.33) (pantothenic acid kinase 2) (hpank2). [source:swissprot;acc:q9bz23]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin activating enzyme e1-like protein. [source:refseq;acc:nm\_006395]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
170.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
122\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.39754\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
118\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
methyltransferase like 2. [source:refseq;acc:nm\_018396]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
43\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.3871\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 3 (ec 2.7.1.33) (pantothenic acid kinase 3) (hpank3). [source:swissprot;acc:q9h999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
119\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
estrogen-related receptor gamma (estrogen receptor related protein 3) (err gamma-2). [source:swissprot;acc:o75454]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
633.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
460.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.37734\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
120\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
high-mobility group 20b; sox-like transcriptional factor; swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily e, member 1-related. [source:refseq;acc:nm\_006339]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5136.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6895.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34247\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
signal-induced proliferation-associated 1-like 1. [source:refseq;acc:nm\_015556]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
494.417\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
359.631\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.37479\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
121\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
4-aminobutyrate aminotransferase, mitochondrial precursor (ec 2.6.1.19) (gamma-amino-n-butyrate transaminase) (gaba transaminase) (gaba aminotransferase) (gaba-at) (gaba-t). [source:swissprot;acc:p80404]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
19.6667\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14.3333\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.3721\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor jun-b. [source:swissprot;acc:p17275]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5579.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7488.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.3422\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
122\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
high-mobility group 20a. [source:refseq;acc:nm\_018200]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5140.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6893.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34112\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh2-b homolog; likely ortholog of mouse sh2 domain-containing putative adapter sh2-b; sh2-b gamma signaling protein; sh2-b alpha signaling protein. [source:refseq;acc:nm\_015503]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
107\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
78\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.37179\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
123\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like 2 isoform a; autophagy-related cysteine endopeptidase 2; autophagin 2. [source:refseq;acc:nm\_052936]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24260.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18172.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33503\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ret finger protein 2 (leukemia associated protein 5) (b-cell chronic lymphocytic leukemia tumor suppressor leu5) (putative tumor suppressor rfp2) (tripartite motif protein 13). [source:swissprot;acc:o60858]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2285.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1681.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.35944\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
124\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3b (map1a/map1b lc3 b) (map1a/1b light chain 3 b). [source:swissprot;acc:q9gzq8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24255.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18168.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33501\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of chromosome condensation (cell cycle regulatory protein). [source:swissprot;acc:p18754]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3248.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2399.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.35386\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
125\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3a (map1a/map1b lc3 a) (map1a/1b light chain 3 a). [source:swissprot;acc:q9h492]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24255.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18168.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33501\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
probable calcium-transporting atpase kiaa0703 (ec 3.6.3.8). [source:swissprot;acc:o75185]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1095.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
812.166\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34876\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
126\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcyphosine. [source:swissprot;acc:q13938]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
472.524\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
635.875\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.3457\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like isoform b. [source:refseq;acc:nm\_178326]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24250\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18164.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33499\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
127\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lipopolysaccharide-binding protein precursor (lbp). [source:swissprot;acc:p18428]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
64\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34375\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor jun-d. [source:swissprot;acc:p17535]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5638.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7523.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33436\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
128\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
luc7-like 2; cgi-74 protein; cgi-59 protein. [source:refseq;acc:nm\_016019]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4355.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5810.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.3341\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial 28s ribosomal protein s22 (s22mt) (mrp-s22) (gk002). [source:swissprot;acc:p82650]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
81.504\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
60.8613\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33918\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
129\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
luc7-like; sarcoplasmic reticulum protein luc7b1. [source:refseq;acc:nm\_018032]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4358.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5811.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33348\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein hspc134 (protein cda04). [source:swissprot;acc:q9by43]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
606.485\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
454.837\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33341\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
130\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
forkhead box p4; fork head-related protein like a; winged-helix repressor foxp4. [source:refseq;acc:nm\_138457]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2234.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2978.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33287\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
maspin precursor (protease inhibitor 5). [source:swissprot;acc:p36952]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33333\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
131\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
forkhead box protein p1 (hspc215). [source:swissprot;acc:q9h334]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2234.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2978.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33285\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serpin b11. [source:swissprot;acc:q96p15]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
42\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
56\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.33333\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
132\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic antiproteinase 2 (cap2) (cap-2) (protease inhibitor 8) (serpin b8). [source:swissprot;acc:p50452]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
forkhead box protein p3 (zinc finger protein jm2) (scurfin). [source:swissprot;acc:q9bzs1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2236.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2980.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33253\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
133\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthethase 2 (paps synthethase 2) (papss 2) (sulfurylase kinase 2) (sk2) (sk 2) [includes: sulfate adenylyltransferase (ec 2.7.7.4) (sulfate adenylate transferase) (sat) (atp-sulfurylase); adenylylsulfate kinase (ec 2.7.1.25) (adenylylsulfate 3'-phosphotransferase) (aps kinase) (adenosine-5'-phosphosulfate 3'-phosphotransferase) (3'- phosphoadenosine-5'-phosphosulfate synthetase)]. [source:swissprot;acc:o95340]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
252\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
335\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.32937\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
gaba(a) receptor-associated protein; gaba(a)-receptor-associated protein. [source:refseq;acc:nm\_007278]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
23421.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17580.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33225\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
134\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gaba-a receptor-associated protein. [source:sptrembl;acc:q9by60]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
21785.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
16426.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.32626\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mms19-like (met18 homolog, s. cerevisiae); homolog of yeast mms19; mms19 (met18 s. cerevisiae)-like. [source:refseq;acc:nm\_022362]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
260.986\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
346.751\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.32862\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
135\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apg3p; pc3-96 protein. [source:refseq;acc:nm\_022488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21785.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
16426.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.32626\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rna polymerase i transcription factor rrn3. [source:refseq;acc:nm\_018427]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
814.485\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
613.614\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.32736\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
136\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear transcription factor y subunit gamma (nf-y protein chain c) (nuclear factor yc) (nf-yc) (ccaat-binding transcription factor subunit c) (cbf-c) (transactivator hsm-1/2). [source:swissprot;acc:q13952]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3620.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4763.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31556\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor e2f2 (e2f-2). [source:swissprot;acc:q14209]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1526.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1150.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.3267\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
137\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat-binding transcription factor subunit b (cbf-b) (nf-y protein chain a) (nf-ya) (caat-box dna binding protein subunit a). [source:swissprot;acc:p23511]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3620.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4763.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31556\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock factor binding protein 1. [source:swissprot;acc:o75506]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1631.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1233.41\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.3225\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
138\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
kv channel interacting protein 1; vesicle apc-binding protein; a-type potassium channel modulatory protein 1. [source:refseq;acc:nm\_014592]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2755.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2094.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31555\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2-17 kda 3 (ec 6.3.2.19) (ubiquitin- protein ligase) (ubiquitin carrier protein) (e2(17)kb 3). [source:swissprot;acc:p47986]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.382\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
154.804\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.32026\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
139\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
associated molecule with the sh3 domain of stam (amsh) like protein. [source:refseq;acc:nm\_020799]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
736.737\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
561.038\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31317\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
potassium channel-interacting protein 4 isoform 4; calsenilin-like protein. [source:refseq;acc:nm\_147183]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
2759.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2099.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31442\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\parbox{\wcA}{\vspace{3pt}\noindent
140\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kv channel interacting protein 2 isoform 4; a-type potassium channel modulatory protein 2; cardiac voltage gated potassium channel modulatory subunit. [source:refseq;acc:nm\_173193]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
2760.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2100.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31425\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/